Pages that link to "Q37932206"
Jump to navigation
Jump to search
The following pages link to Whole cancer genome sequencing by next-generation methods (Q37932206):
Displaying 50 items.
- Microfluidic Devices for Forensic DNA Analysis: A Review (Q26741377) (← links)
- Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing (Q26768533) (← links)
- From tissue to molecular phenotyping: pre-analytical requirements heidelberg experience (Q26864637) (← links)
- Advances in the Molecular Analysis of Soft Tissue Tumors and Clinical Implications (Q27021848) (← links)
- Next generation sequencing applications for breast cancer research. (Q27690994) (← links)
- Standardization and quality management in next-generation sequencing (Q28077041) (← links)
- Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies (Q28293243) (← links)
- Detecting somatic mutations in genomic sequences by means of Kolmogorov-Arnold analysis (Q28608224) (← links)
- Enrichment and single-cell analysis of circulating tumor cells. (Q30357985) (← links)
- Managing Expectational Language: Translational genetic professionals consider the clinical potential of next-generation sequencing technologies (Q33686458) (← links)
- Validation and assessment of variant calling pipelines for next-generation sequencing (Q34030865) (← links)
- Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail (Q34113504) (← links)
- Formalin fixation in the ‘‐omics’ era: a primer for the surgeon‐scientist (Q34263623) (← links)
- Whole genome sequencing for lung cancer. (Q34352229) (← links)
- Prospective genetic profiling of squamous cell lung cancer and adenosquamous carcinoma in Japanese patients by multitarget assays (Q34460043) (← links)
- BRAF-mutant melanoma: treatment approaches, resistance mechanisms, and diagnostic strategies. (Q34667825) (← links)
- Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications (Q34764681) (← links)
- DNA qualification workflow for next generation sequencing of histopathological samples (Q34769357) (← links)
- Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy (Q34866510) (← links)
- An emerging place for lung cancer genomics in 2013. (Q35027068) (← links)
- An efficient and scalable graph modeling approach for capturing information at different levels in next generation sequencing reads (Q35101456) (← links)
- Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis. (Q35323457) (← links)
- Molecular characterization of gallbladder cancer using somatic mutation profiling (Q35597012) (← links)
- Rapid, optimized interactomic screening (Q35665985) (← links)
- HER2/neu-directed therapy for biliary tract cancer (Q35748129) (← links)
- Effective quality management practices in routine clinical next-generation sequencing (Q35922622) (← links)
- Genetics, diagnosis and management of colorectal cancer (Review). (Q35934455) (← links)
- ALK Inhibitors, a Pharmaceutical Perspective (Q35972157) (← links)
- Clinical integration of next-generation sequencing technology (Q36343255) (← links)
- Key anticipated regulatory issues for clinical use of human induced pluripotent stem cells. (Q36934047) (← links)
- Application of next-generation sequencing in clinical oncology to advance personalized treatment of cancer (Q37183603) (← links)
- Targeted next-generation sequencing panel (ThyroSeq) for detection of mutations in thyroid cancer (Q37275937) (← links)
- Image-Guided Biopsy in the Era of Personalized Cancer Care: Proceedings from the Society of Interventional Radiology Research Consensus Panel (Q37324763) (← links)
- Next generation sequencing and a new era of medicine (Q37409165) (← links)
- Clinical application of high-throughput genomic technologies for treatment selection in breast cancer (Q37691245) (← links)
- Recent advances in the molecular characterization of circulating tumor cells (Q37693504) (← links)
- Molecular testing in melanoma (Q37997543) (← links)
- Molecular diagnosis of leukemia (Q38018998) (← links)
- Best practices for companion diagnostic and therapeutic development: translating between the stakeholders (Q38022383) (← links)
- Overcoming implementation challenges of personalized cancer therapy (Q38031117) (← links)
- Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. (Q38037294) (← links)
- Transcriptome alterations induced by cigarette smoke (Q38041993) (← links)
- The role of high-throughput technologies in clinical cancer genomics (Q38088010) (← links)
- Testing for anaplastic lymphoma kinase rearrangement to target crizotinib therapy: oncology, pathology and health economic perspectives (Q38101614) (← links)
- Lessons from next-generation sequencing analysis in hematological malignancies. (Q38123015) (← links)
- Oral cavity and oropharyngeal squamous cell carcinoma genomics (Q38126153) (← links)
- Harnessing massively parallel sequencing in personalized head and neck oncology. (Q38190022) (← links)
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer (Q38203468) (← links)
- Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine (Q38218474) (← links)
- Melanoma: Advances in Targeted Therapy and Molecular Markers (Q38557217) (← links)